Lv61
3040 积分 2022-11-17 加入
Lymphocyte alterations and elevated complement signaling are key features of refractory myasthenia gravis
1个月前
已完结
Effective use of BCMA-targeting bispecific T cell-engaging antibody in treatment-refractory LRP4+ myasthenia gravis
2个月前
已完结
New therapies for autoimmune myasthenia gravis
2个月前
已完结
Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders
2个月前
已完结
What Is Myasthenia Gravis?
2个月前
已完结
Memory B cells
2个月前
已完结
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
2个月前
已完结
A small, but vocal, brain
2个月前
已关闭
Therapeutic approaches in adults with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A review of current evidence
2个月前
已完结
Migraine: epidemiology and systems of care
2个月前
已完结
皖公网安备34019202002308
